| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Caring People offering 24 hour home care service for the elderly and help seniors daily living at home. Hire 24-hour caregivers for your loved one.
NinePoint Medical is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Welcome Nursing Home Inc is a Oberlin, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HealthFrontier (Canada), Inc. is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.